AVERA WESKOTA MEMORIAL MEDICAL CENTE — History
CCN 431324 | 3-year financial timeline | COVID resilience: 61/100
🛡️ Public data only — no PHI permitted on this instance.
$5M
Latest Revenue (FY2022)
+4.2%
Revenue CAGR (3yr)
13.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $5M | $5M | $5M | +4.2% | +4.2% |
| Operating Expenses | $5M | $5M | $5M | -2.0% | +2.3% |
| Operating Margin | 9.7% | 7.5% | 13.0% | +72.8% | +15.9% |
| Net Income | $0M | $0M | $1M | +80.0% | +20.8% |
| Licensed Beds | 16 | 16 | 16 | +0.0% | +0.0% |
| Total Patient Days | 544 | 571 | 563 | -1.4% | +1.7% |
| Medicare Day % | 95% | 88% | 89% | +1.6% | -3.1% |
| Medicaid Day % | nan% | nan% | 5% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 61/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +8.6% ($5M → $5M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.2%
This Hospital
+7.6%
State Avg
Latest Margin
13.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $6M | 14.7% |
| FY2024 (proj) | $6M | 16.3% |
| FY2025 (proj) | $6M | 18.0% |